Case report: Low-dose interleukin-2: a treatment of bullous pemphigoid with predominantly perifollicular blistering caused by PD-1/PD-L1 inhibitor

Low-dose IL-2 could be an effective therapeutic choice for treating BP caused by PD-1/PD-L1 inhibitors.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2024-12-10
DOI
https://doi.org/10.3389/fimmu.2024.1496413
Citations
2
Primary Topic
Autoimmune Bullous Skin Diseases
Type
article
Field-Weighted Citation Impact
0.85

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case report: Low-dose interleukin-2: a treatment of bullous pemphigoid with predominantly perifollicular blistering caused by PD-1/PD-L1 inhibitor

Jianbo Tong, Xianwei Cao, Yingyue Zhang
2 citations
Frontiers in Immunology
Autoimmune Bullous Skin Diseases
0.85
article

Case report: Low-dose interleukin-2: a treatment of bullous pemphigoid with predominantly perifollicular blistering caused by PD-1/PD-L1 inhibitor

Jianbo Tong, Xianwei Cao, Yingyue Zhang
article en
2 citations

Abstract

Low-dose IL-2 could be an effective therapeutic choice for treating BP caused by PD-1/PD-L1 inhibitors.

Frontiers in ImmunologyVol. 15
Nanchang University (CN), Jiangxi Provincial Academy of Medical Sciences (CN)
National Natural Science Foundation of China
Responsible consumption and production
Openalex Percentile: Top 24%
Autoimmune Bullous Skin Diseases
0.85
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.